17, 2024 — Researchers discovered they could boost survival to 92% for patients with advanced Hodgkin ... B-Cell Lymphoma June 19, 2024 — Researchers have developed a non-chemotherapy ...

Non-Hodgkin lymphoma is a cancer that affects lymphocytes, a type of white blood cells in the lymphatic system. They are generally classified according to the cancer's growth rate as high grade ...

At the 2024 American Society of Hematology (ASH) Annual Meeting & Exposition last month, the company announced positive ...

Bristol Myers Squibb Canada (BMS) is pleased to announce Health Canada's approval of Breyanzi® (lisocabtagene maraleucel), a type of chimeric antigen receptor T cell (CAR T) therapy, for the treatment ...

A Phase I study included 13 patients with a variety of relapsed B-cell NHL (five follicular, three mantle cell, three DLBCL, two chronic lymphocytic leukemia/small-cell lymphoma [CLL/SLL]).

Three weeks before the state election last October the then long-serving police officer revealed she had been diagnosed with follicular Non-Hodgkin’s Lymphoma. But even with the time it has ...

The addition of Monjuvi to standard-of-care therapy reduced the risk of disease progression, relapse, or death in patients with relapsed/refractory follicular lymphoma Compared to placebo, the ...

If you have celiac disease, you also likely have a higher-than-normal risk of developing non-Hodgkin lymphoma. This may seem frightening ... A review of studies notes that the biggest studies reported ...